A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

May 7, 2019

Primary Completion Date

August 5, 2020

Study Completion Date

August 5, 2020

Conditions
Chronic Gout
Interventions
DRUG

SEL-212

Administered as specified in the treatment arm

DRUG

KRYSTEXXA®

Administered as specified in the treatment arm

Trial Locations (43)

11201

NYU Langone Ambulatory Care Brooklyn Heights, Brooklyn

16635

Altoona Center for Clinical Research, Duncansville

19610

Clinical Research Center of Reading, LLC, Wyomissing

20902

The Center for Rheumatology and Bone Research, Wheaton

21502

Klein & Associates, M.D., P.A., Cumberland

21740

Klein & Associates, M.D., P.A., Hagerstown

27710

Duke University Medical Center, Durham

28210

DJL Clinical Research, Charlotte

28451

Cape Fear Arthritis Care PLLC, Leland

28541

Cape Fear Arthritis Care PLLC, Leland

30265

Better Health Clinical Research, Inc., Newnan

30501

Arthritis Center of North Georgia, Gainesville

32806

Accelerated Enrollment Solutions (AES), Orlando

Rheumatology Associates of Central Florida, PA, Orlando

33014

Panax Clinical Research, Miami Lakes

33143

QPS-Medical Research Assoc LLC, Miami

Well Pharma Medical Research Corp., Miami

33603

Clinical Research of West Florida, Inc., Tampa

33614

Advent Health Group Multispecialty at Habana and Bruce B. Downs, Tampa

33765

Clinical Research of West Florida, Clearwater

36207

Pinnacle Research Group, LLC, Anniston

38305

West Tennessee Research Institute, LLC, Jackson

39202

Elite Clinical Research, LLC, Jackson

40213

L-MARC Research Center, Louisville

45242

New Horizons Clinical Research, Cincinnati

48109

University Hospital, Ann Arbor

60640

Great Lakes Clinical Trials, Chicago

64014

TEST, Blue Springs

72205

Baptist Health Center for Clinical Research, Little Rock

73102

Arthritis & Rheumatology Center of Oklamhoma, PLLC, Oklahoma City

75150

Southwest Rheumatology Research, LLC, Mesquite

75231

Metroplex Clinical Research Center, Dallas

77099

Pioneer Research Solutions, Inc., Houston

78731

Austin Regional Clinic, Austin

78745

Tekton Research, Austin

79124

Amarillo Center for Clinical Research, Amarillo

83404

Institute of Arthritis Research, Idaho Falls

85351

Arizona Arthritis & Rheumatology Research, PLLC, Sun City

90720

Valerius Medical Group and Research Center of Greater Long Beach, Inc., Los Alamitos

91722

Medvin Clinical Research, Covina

92064

Arthritis Care and Research Center, Poway

92119

MD Strategies Research Centers, San Diego

01605

Clinical Pharmacology Study Group, Worcester

All Listed Sponsors
lead

Selecta Biosciences, Inc.

INDUSTRY

NCT03905512 - A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy | Biotech Hunter | Biotech Hunter